Skip to Content
Merck
CN
  • Synthesis of radioiodine labeled dibenzyl disulfide for evaluation of tumor cell uptake.

Synthesis of radioiodine labeled dibenzyl disulfide for evaluation of tumor cell uptake.

Bioorganic & medicinal chemistry (2004-02-26)
Eun Kyoung Ryu, Yearn Seong Choe, Sang Sung Byun, Kyung-Han Lee, Dae Yoon Chi, Yong Choi, Byung-Tae Kim
ABSTRACT

Benzyl 4-halobenzyl and ally benzyl disulfide were synthesized as diallyl disulfide analogues and their tumor growth inhibitory effects on the cancer cells (SNU C5 and MCF-7) were comparable to that of diallyl disulfide, indicating that the disulfide functional group was responsible for the tumor growth inhibitory effects. Cu(I)-assisted radioiodination of benzyl 4-bromobenzyl disulfide gave benzyl 4-[123I/125I]iodobenzyl disulfide in 30-40% radiochemical yield. The radiolabeled disulfide was taken up by the cancer cells in a time-dependent manner, and the uptake was inhibited by the pretreatment of S-methyl methanethiosulfonate (MMTS), phorone and diallyl disulfide. This study suggested that the radiolabeled dibenzyl disulfide was taken up by the cancer cells via thiol-disulfide exchange and retained inside the cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Dibenzyl sulfide, ≥95.0% (HPLC)